Smith, Tawny Bettinger, Pharm.D.
Adjunct Assistant Professor
Director, Psychiatric Pharmacy Program
(512)324-2027 tbsmith@seton.org

Bettinger TL, Crismon ML. Lithium. Burton M, Evans W, Schentag J, Shaw L, (eds). Applied pharmacokinetics: principles of therapeutic drug monitoring, 4th ed. Baltimore: Lippincott Williams & Wilkins. (in press)

Trivedi MH, Bettinger TL, Kleiber B. Treatment Resistant Depression. In: Preskorn S, ed. Handbook of Experimental Pharmacology on Antidepressants. New York: Springer-Verlag. (in press)

Winans EA, Bettinger TL. Mood Disorders: Bipolar and Major Depressive Disorders. In: Schumock GT, Brundage DM, Chessman KH, et al, eds. Pharmacotherapy Self-Assessment Program, 5th ed. Psychiatry I module. Kansas City, Missouri: American College of Clinical Pharmacy. (in press)

Bettinger TL, Crismon ML, Trivedi MH, Grannemann B, Shon S. Clinician adherence to a major depressive disorder algorithm in the public mental health sector. Psychiatric Services 2004;55:703-705.

Trivedi MH, Kern JK, Marcee AK, Kleiber B, Grannemann B, Bettinger T, Altshuler KZ, McClelland A. Development and implementation of computerized clinical guidelines: barriers and solutions. Methods Inf Med. 2002;41(5):435-42.

Patel N, Dorson PG, Bettinger TL. Sudden late onset of clozapine induced agranulocytosis: implications for hematologic monitoring. Ann Pharmacother 2002;36:1012-5.

Bettinger T, Trivedi MH. Newer antidepressant medications. DMJ 2001;87:522-526.

Bettinger TL, Mendelson SC, Dorson PG, Crismon ML. Olanzapine-induced glucose dysregulation. Ann Pharmacother 2000;34:865-7.

More information about Dr. Bettinger
> Education & Board Certifications
> Return to Dr. Bettinger's Home Page